Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$6.12 +0.82 (+15.47%)
At close: Nov 11, 2026 · 4:00 PM EST

Cumberland Pharmaceuticals (CPIX) Gains from Sales and Divestitures (2023)

Updated

Cumberland Pharmaceuticals' Gains from Sales and Divestitures was -$2,691 in FY2024, compared with -$20,256 in FY2023.

Analysis

Cumberland Pharmaceuticals (CPIX) Gains from Sales and Divestitures (2023) Analysis & Trends

  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was -$20,256 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cumberland Pharmaceuticals 79.41 Mn 79.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -20,256.00
API Access

Cumberland Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CPIX&period=max&api_key=YOUR_API_KEY